G. Markus

发表

Plasminogen Activator System Localization in 60 Cases of Ductal Carcinoma In Situ

J. Winston, T. Hurd, S. Sait, 2007, Annals of Surgical Oncology.

Overexpression of Urinary Plasminogen Activator (uPA) Protein and mRNA in Thyroid Carcinogenesis

Q. Chu, T. Loree, D. Tan, 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.

D. Tan, T. Hurd, S. Sait, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cancer Cells Release a Covalent Complex Containing Disulfide-Linked Domains from Urinary Plasminogen Activator, Neural Cell Adhesion Molecule, and Haptoglobin α and β Chains☆☆☆

G. Markus, S. Harvey, R. Dillman, 1997 .

Esterase activities in the zymogen moiety of the streptokinase-plasminogen complex.

G. Markus, K. Reddy, 1974, The Journal of biological chemistry.

Activator activities of the transient forms of the human plasminogen-streptokinase complex during its proteolytic conversion to the stable activator complex.

G. Markus, J. Evers, G. Hobika, 1976, The Journal of biological chemistry.

Comparison of some properties of native (Glu) and modified (Lys) human plasminogen.

G. Markus, J. Evers, G. Hobika, 1978, The Journal of biological chemistry.

Ligand-induced conformational changes in ribonuclease.

E. Barnard, G. Markus, B. A. Castellani, 1968, The Journal of biological chemistry.

The induction of the plasminogen activator system during phorbol ester (PMA)-induced differentiation in HL-60 leukemic cells

G. Markus, J. Corasanti, A. Gruneiro, 1995 .

Different induction pathways for urokinase (u-PA) in A431 cells by EGF and by the phorbol ester, TPA

G. Markus, T. Kessler, 1993 .

The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation.

R. Priore, G. Markus, F. Wissler, 1979, The Journal of biological chemistry.

Plasminogen activator activity and composition in human breast cancer.

G. Markus, J. Evers, G. Hobika, 1982, Cancer research.

Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization.

S. Sait, G. Markus, S. Harvey, 1999, The American journal of pathology.

The relevance of plasminogen activators to neoplastic growth. A review of recent literature.

G. Markus, 1988, Enzyme.

Conformational changes in aspartate transcarbamylase. I. Proteolysis of the intact enzyme.

G. Markus, D. K. McClintock, 1968, The Journal of biological chemistry.

Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors.

S. Kohga, G. Markus, A. Mittelman, 1983, Cancer research.

Content and characterization of plasminogen activators in human lung tumors and normal lung tissue.

G. Markus, J. Evers, G. Hobika, 1980, Cancer research.

Plasminogen activator content of gynecological tumors and their metastases.

M. Piver, G. Markus, S. Camiolo, 1987, Gynecologic oncology.

The disulfide bonds of rabbit γ-globulin and its fragments

G. Markus, D. Pressman, A. Grossberg, 1962 .

Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.

G. Markus, C. Ambrus, 1960, The American journal of physiology.

Localization of plasminogen activators in human colon cancer by immunoperoxidase staining.

S. Kohga, G. Markus, S. Harvey, 1985, Cancer research.

Collagenases and Other Proteases Directed Migration of Murine and Human Tumor Cells to Updated

G. Markus, V. Terranova, D. Maslow, 2006 .

Structural Effects of Anionic Azo Dyes on Serum Albumin1

G. Markus, F. Karush, 1958 .

The Role of Hemostasis and Fibrinolysis in the Metastatic Spread of Cancer

G. Markus, 1984, Seminars in thrombosis and hemostasis.

ELECTROLYTIC REDUCTION OF THE DISULFIDE BONDS OF INSULIN.

G. Markus, 1964, The Journal of biological chemistry.

Conformational changes in plasminogen, their effect on activation, and the agents that modulate activation rates — a review

G. Markus, 1996 .

Clinical pharmacology of various types of fibrinolytic enzyme preparations

J. B. Fishman, G. Markus, D. Kline, 1960 .

Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen.

G. Markus, F. Wissler, J. Depasquale, 1978, The Journal of biological chemistry.

Selective Inactivation of the Plasminogen Contaminant in Thrombin

G. Markus, C. Ambrus, Clara M. Ambrus, 1960, Nature.

Mechanism of activation of human plasminogen by streptokinase. Presence of active center in streptokinase-plasminogen complex.

G. Markus, K N Reddy, G Markus, 1972, The Journal of biological chemistry.

Casein, a powerful enhancer of the rate of plasminogen activation

G. Markus, S. Harvey, G. Tritsch, 1993 .

Interference with dimethylhydrazine induction of colon tumors in mice by epsilon-aminocaproic acid.

G. Markus, G. Hobika, J. Corasanti, 1982, Science.

Characterization of a family of high-molecular-weight plasminogen activators secreted by a lung tumor cell line.

M. Ross, G. Markus, S. Harvey, 1991, Biochimica et biophysica acta.

Further evidence for an active center in streptokinase-plasminogen complex; interaction with pancreatic trypsin inhibitor.

G. Markus, K. Reddy, 1973, Biochemical and biophysical research communications.

THE INTERACTION OF STREPTOKINASE WITH PLASMINOGEN. I. FUNCTIONAL PROPERTIES OF THE ACTIVATED ENZYME.

G. Markus, W. C. Werkheiser, 1964, The Journal of biological chemistry.

Structural Effects of the Interaction of Human Serum Albumin with Sodium Decyl Sulfate1

G. Markus, F. Karush, 1957 .

Change in antibody conformation induced by hapten.

G. Markus, D. Pressman, A. Grossberg, 1965, Proceedings of the National Academy of Sciences of the United States of America.

Protein substrate conformation and proteolysis.

G. Markus, G Markus, 1965, Proceedings of the National Academy of Sciences of the United States of America.

The Disulfide Bonds of Human Serum Albumin and Bovine γ-Globulin1

G. Markus, F. Karush, 1957 .

Tryptic hydrolysis of human serum albumin. The pattern of initial fragmentation.

G. Markus, D. K. McClintock, B. A. Castellani, 1967, The Journal of biological chemistry.

MECHANISM OF PROTECTION BY ANIONIC DETERGENTS AGAINST DENATURATION OF SERUM ALBUMIN.

G. Markus, R. Love, F. Wissler, 1964, The Journal of biological chemistry.

Phosphoenolpyruvate carboxylase of Escherichia coli. Purification and some properties.

G. Markus, R. Wohl, R. C. Wohl, 1972, The Journal of biological chemistry.

Plasminogen Activators in Human Malignant Melanoma

S. Kohga, G. Markus, C. Karakousis, 1984 .

Plasminogen Activators In Human Malignant Melanoma

S. Kohga, G. Markus, C. Karakousis, 1984, Thrombosis and Haemostasis.

Comparison of the immunohistochemical localisation of urokinase in normal and cancerous human colon tissue

S. Kohga, G. Markus, S. Harvey, 1989 .

Affinity chromatography of thymidine kinase from a rat colon adenocarcinoma.

G. Markus, E. Kowal, 1976, Preparative biochemistry.

Urokinase-like plasminogen activators of unusually high molecular weight secreted by a cell line derived from a human lung cancer case.

G. Markus, S. Harvey, J. Minowada, 1982, The Journal of biological chemistry.

A polarographic study of Evans blue and its combination with plasma proteins.

G. Markus, J. P. Baumberger, 1954, The Journal of biological chemistry.

Secretion of plasminogen activators by human colorectal and gastric tumor explants

G. Markus, S. Harvey, J. Madeja, 1988, Clinical & Experimental Metastasis.

Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity

G. Markus, J. Evers, G. Hobika, 1981, International journal of cancer.

Augmentation of streptokinase activator activity by fibrinogen or fibrin.

G. Markus, J. Evers, G. Hobika, 1980, Thrombosis research.

Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues.

S. Kohga, G. Markus, L. Englander, 1984, Cancer research.

Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification.

G. Markus, A. Mittelman, J. Evers, 1980, Journal of the National Cancer Institute.

THE INTERACTION OF STREPTOKINASE WITH PLASMINOGEN. II. THE KINETICS OF ACTIVATION.

G. Markus, W. C. Werkheiser, 1964, The Journal of biological chemistry.

On the formation of different types of plasmin by streptokinase activation.

G. Markus, C. Ambrus, 1960, The Journal of biological chemistry.

Directed migration of murine and human tumor cells to collagenases and other proteases.

G. Markus, V. Terranova, D. Maslow, 1989, Cancer research.

A model for hydropathy-based peptide interactions.

R. Parthasarathy, G. Markus, G. Tritsch, 1989, Archives of biochemistry and biophysics.

Co-expression of urokinase with haptoglobin in human carcinomas.

J. Geradts, T. Hurd, S. Sait, 2009, The Journal of surgical research.

Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains.

G. Markus, S. Harvey, R. Dillman, 1997, Archives of biochemistry and biophysics.

Ligand-stabilized conformations in serum albumin.

G. Markus, D. K. McClintock, B. A. Castellani, 1967, The Journal of biological chemistry.

Urokinase secretion from human colon carcinomas induced by endogenous diglycerides.

S. Winawer, E. Friedman, G. Markus, 1990, Cancer research.

Conformational changes in aspartate transcarbamylase. 3. A functional model for allosteric behavior.

G. Markus, J. Bussel, D. K. McClintock, 1971, The Journal of biological chemistry.

Conformational changes in aspartate transcarbamylase. II. Concerted or sequential mechanism?

G. Markus, D. K. McClintock, 1969, Journal of Biological Chemistry.

Epidermal Growth Factor and 12-Tetradecanoyl Phorbol 13-Acetate Induction of Urokinase in A431 Cells

G. Markus, T. Kessler, 1991, Seminars in Thrombosis and Hemostasis.

Co-expression of urokinase with haptoglobin in human carcinomas.

J. Geradts, T. Hurd, S. Sait, 2009, The Journal of surgical research.